Literature DB >> 21275912

Significant effects on neonatal morbidity and mortality after regional change in management of post-term pregnancy.

Charlotta Grunewald1, Stellan Håkansson, Sissel Saltvedt, Karin Källén.   

Abstract

OBJECTIVE: To evaluate the effects on neonatal morbidity of a regional change in induction policy for post-term pregnancy from 43(+0) to 42(+0) gestational weeks (GWs). DESIGN AND
SETTING: Nationwide retrospective register study between 2000 and 2007. POPULATION: All singleton pregnancies with a gestational age of >41(+2) GW (n= 119,198).
METHODS: All Swedish counties were divided into three groups where study group allocation was designated by the proportion of pregnancies >42(+2) GW among all pregnancies of >41(+2) GW. Stockholm county formed a separate group. MAIN OUTCOME MEASURES: Perinatal morbidity.
RESULTS: In counties with the most active management, 19% of pregnancies >41(+2) GW were delivered at >42(+2) GW during 2000-2004 compared to 7.1% in 2005-2007. In the least active counties, corresponding figures were 21.0% compared to 19.4%. During 2005-2007, the odds ratios for meconium aspiration and 5-minute Apgar score of ≤6 in the least compared to most active counties, were 1.55 (95% CI: 1.03-2.33) and 1.26 (95% CI: 1.06-1.51). In Stockholm >42(+2) GW seen among pregnancies of >41(+2) decreased from 21.0% in 2000-2004 to 5.9% in 2005-2007. Reduced perinatal death risks by 48%, meconium aspiration of 51% and low Apgar scores by 31% in 2005-2007 compared with 2000-2004 were observed. Rates of operative deliveries at >41(+2) GW in Stockholm were unaltered.
CONCLUSION: A significant reduction in perinatal morbidity was found, with no influence on operative delivery rates for post-term pregnancy in Stockholm. We advocate a nationwide change toward more active management of post-term pregnancies.
© 2010 The Authors Acta Obstetricia et Gynecologica Scandinavica© 2010 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Year:  2010        PMID: 21275912     DOI: 10.1111/j.1600-0412.2010.01019.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

1.  Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial.

Authors:  Ulla-Britt Wennerholm; Sissel Saltvedt; Anna Wessberg; Mårten Alkmark; Christina Bergh; Sophia Brismar Wendel; Helena Fadl; Maria Jonsson; Lars Ladfors; Verena Sengpiel; Jan Wesström; Göran Wennergren; Anna-Karin Wikström; Helen Elden; Olof Stephansson; Henrik Hagberg
Journal:  BMJ       Date:  2019-11-20

2.  Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials.

Authors:  Mårten Alkmark; Judit K J Keulen; Joep C Kortekaas; Christina Bergh; Jeroen van Dillen; Ruben G Duijnhoven; Henrik Hagberg; Ben Willem Mol; Mattias Molin; Joris A M van der Post; Sissel Saltvedt; Anna-Karin Wikström; Ulla-Britt Wennerholm; Esteriek de Miranda
Journal:  PLoS Med       Date:  2020-12-08       Impact factor: 11.069

3.  Stillbirth in term and late term gestations in Stockholm during a 20-year period, incidence and causes.

Authors:  Hanna Åmark; Christina Pilo; Ingela Hulthén Varli
Journal:  PLoS One       Date:  2021-05-25       Impact factor: 3.240

4.  Study protocol of SWEPIS a Swedish multicentre register based randomised controlled trial to compare induction of labour at 41 completed gestational weeks versus expectant management and induction at 42 completed gestational weeks.

Authors:  Helen Elden; Henrik Hagberg; Anna Wessberg; Verena Sengpiel; Andreas Herbst; Maria Bullarbo; Christina Bergh; Kristian Bolin; Snezana Malbasic; Sissel Saltvedt; Olof Stephansson; Anna-Karin Wikström; Lars Ladfors; Ulla-Britt Wennerholm
Journal:  BMC Pregnancy Childbirth       Date:  2016-03-07       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.